The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| EKSO BIONICS HLDGS INC | COM | 282644301 | 3,678 | 774,400 | SH | SOLE | 0 | 774,400 | 0 | ||
| KADMON HLDGS INC | COM | 48283N106 | 393 | 100,184 | SH | SOLE | 0 | 100,184 | 0 | ||
| BELLEROPHON THERAPEUTICS INC | COM NEW | 078771300 | 11,746 | 1,153,846 | SH | SOLE | 0 | 1,153,846 | 0 | ||
| CORVUS PHARMACEUTICALS INC | COM | 221015100 | 152 | 38,010 | SH | SOLE | 0 | 38,010 | 0 | ||
| SCYNEXIS INC | COM NEW | 811292200 | 1,372 | 311,143 | SH | SOLE | 0 | 311,143 | 0 | ||